Skip to main content
Premium Trial:

Request an Annual Quote

Psychiatric Genomics to Use High Throughput Genomics Array Kits In Drug Search

NEW YORK, Feb. 5-Psychiatric Genomics will use array kit products from Tucson, Ariz.-based High Throughput Genomics in its search for drugs to treat psychiatric disorders, the companies said on Jan. 31.


As part of the agreement, PsyGenomics will designate genes of interest to be included into the custom-made kits. The kits will be incorporated into PsyGenomics' own drug discovery platform.


The companies did not reveal financial details of the arrangement.


HTG's ArrayPlate kits, designed for drug discovery and diagnostic development, are 96-well universal array microplates with custom reagent kits. The plates are designed to allow multiple assays per well.


Psychiatric Genomics, based in Gaithersburg, Md., focuses on new treatments for mental illness. Its research includes novel gene discovery, high-throughput cellular screening, and lead candidate optimization.


The privately held company was founded in 2000. Oxford Bioscience Partners is the lead investor.


High Throughput Genomics was established as a subsidiary of Tucson combinatorial chemistry firm Systems Integration Drug Discovery Company in 1997. When that company was sold to San Diego's Discovery Partners International in 2001, HTG was spun off to SIDDCO shareholders. It is also privately held.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.